Alberto Santiago Cornier
Clinical Genetics (M.D.) · Santurce, PRNPI 1285763144
Payments from drug & device makers
Across 535 payments — averaging $827.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$150K
- Takeda Pharmaceuticals U.S.A., Inc.$114K
- Sanofi$110K
- Biomarin Pharmaceutical Inc.$48K
- Sarepta Therapeutics, Inc.$10K
- Acadia Pharmaceuticals Inc$3K
- plus $6K from 12 others
What the payments were for
- Consulting fees$30,5368%
- Speaking & faculty fees$307,88378%
- Travel & lodging$45,45512%
- Food & beverage$10,3083%
- Education$1930%
- Gifts$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 203 | $150,044 |
| Takeda Pharmaceuticals U.S.A., Inc. | 177 | $114,319 |
| Sanofi | 87 | $110,465 |
| Biomarin Pharmaceutical Inc. | 14 | $48,148 |
| Sarepta Therapeutics, Inc. | 17 | $10,354 |
| Acadia Pharmaceuticals Inc | 2 | $2,892 |
| Cycle Pharmaceuticals Inc | 4 | $2,514 |
| Chiesi USA, Inc. | 4 | $1,465 |
| PTC Therapeutics, Inc. | 4 | $1,448 |
| Biogen | 9 | $245 |
| PBG Puerto Rico LLC | 5 | $120 |
| Genentech, Inc. | 1 | $107 |
| Novartis | 1 | $101 |
| GSK | 1 | $97 |
| Ultragenyx Pharmaceutical Inc. | 3 | $90 |
| Pfizer Pharmaceuticals LLC | 1 | $20 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Amicus Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sapropterin Dihydrochloride | 22 | $113,116 |
| CarnitorLevocarnitine | 12 | $907 |
Paid to pharmacies, not to this prescriber.
Other clinical genetics (m.d.) in Santurce
- Cristel Chapel-CrespoManati$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.